-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Recently, the official website of CDE showed that Hengrui Medicine’s clinical trial application for HRS-2261 tablets was approved for the treatment of chronic cough
Chronic cough lasting ≥8 weeks, no evidence of lung disease on chest X-ray, and cough as the main or only symptom
At present, Hengrui's product pipeline is very rich, and it has carried out forward-looking layout in many fields such as oncology, autoimmune diseases, pain management, ophthalmology, cardiovascular diseases, metabolic diseases, infectious diseases, and respiratory diseases